1. Division of Immunology, Aichi Cancer Center, Nagoya;
2. Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya;
3. Division of Epidemiology and Prevention, Aichi Cancer Center, Nagoya;
4. Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo;
5. Division of Molecular Science, Tokai University School of Medicine, Isehara;
6. Human Leukocyte Antigen (HLA) Laboratory, Nonprofit Organization (NPO), Kyoto;
7. Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine, Isehara;
8. Japanese Red Cross Central Blood Institute, Tokyo;
9. Japanese Red Cross Nagoya First Hospital, Nagoya;
10. International Medical Center of Japan, Tokyo, Japan